SEP 24, 2026 · JOURNAL ARTICLE
Molecular insights into GLP-1 receptor agonists and emerging metabolic-inflammatory targets in Hidradenitis suppurativa
Expert Opinion on Therapeutic Targets
INTRODUCTION: Hidradenitis suppurativa (HS) is increasingly recognized as a systemic immunometabolic disease associated with obesity, insulin resistance, and metabolic syndrome (Me